Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
14.06
+0.45 (3.31%)
At close: Oct 23, 2026

Frontier Biotechnologies Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,2676,7613,6563,7166,4656,688
Market Cap Growth
-4.35%84.94%-1.61%-42.53%-3.33%-3.43%
Enterprise Value
4,7796,4433,4423,0555,3915,318
Last Close Price
14.0618.059.769.9217.2618.59

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.9354.8028.2432.5276.29165.12
PB Ratio
5.097.713.202.773.873.65
P/TBV Ratio
5.729.023.693.344.574.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
12.6452.2226.5926.7463.61131.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.410.460.360.280.170.16
Net Debt / Equity Ratio
-0.47-0.35-0.39-0.42-0.58-0.65
Net Debt / EBITDA Ratio
32.151.301.871.862.734.19
Net Debt / FCF Ratio
-11.331.202.321.422.242.08
Asset Turnover
0.220.070.070.050.030.02
Inventory Turnover
1.521.581.911.421.471.91
Quick Ratio
4.472.212.812.654.643.76
Current Ratio
4.962.453.092.905.073.95
Return on Equity (ROE)
-2.10%-26.56%-16.21%-21.83%-20.38%-13.36%
Return on Assets (ROA)
-1.20%-9.59%-8.76%-9.45%-10.08%-7.95%
Return on Capital Employed (ROCE)
-2.20%-22.30%-19.50%-19.60%-18.70%-15.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.42%-3.96%-5.51%-8.85%-5.52%-3.89%
FCF Yield
0.82%-3.79%-5.23%-10.67%-6.64%-8.53%
Buyback Yield / Dilution
0.62%0.17%0.24%-2.69%-0.79%-25.23%